Dr Timothy Wells joined Medicines for Malaria Venture in October 2007 as the Chief Scientific Officer. He has responsibility for the Research and Development Portfolio, which covers over 50 projects from screening, through to one launched product and two products currently preparing for registration.
Prior to joining MMV, he was Senior Executive Vice President Research at Serono. Prior to this he worked at the Glaxo Institute for Molecular Biology. He has over 180 scientific publications, and several patent applications.
He has a PhD in Chemistry from Imperial College, London for Protein Engineering studies on enzyme catalysis, with Sir Alan Fersht. He was awarded a ScD in Biology from the University of Cambridge for his later work on Cytokine Biology. He is a Fellow of the Royal Society of Chemistry.